References
- Angeli P, Ginès P, Wong F, et al; International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64(4):531-537. PubMed 25631669
- Wong F, Pappas SC, Curry MP, et al; CONFIRM Study Investigators. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome‑AKI. N Engl J Med. 2021;384(9):818-828. PubMed 33657294
- Ginès P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123(6):1839-1847. PubMed 12454841
- Thursz MR, Richardson P, Allison M, et al; STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372(17):1619-1628. PubMed 25901427
⚑ Reference 4 (Thursz/STOPAH) is a trial of steroids vs pentoxifylline for alcoholic hepatitis — its placement on the HRS page should be reviewed for relevance. Reference 3 (Ginès 2002) covers TIPS vs paracentesis+albumin; the page cited this as a 1999 albumin-after-LVP paper — year and context should be verified.